Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children

Journal of Clinical Lipidology

Volumn 9, Issue 2, 2015, Pages 195-200

  Agirbasli, Mehmet ^a   Tanrikulu, Azra ^b   Acar Sevim, Busra ^a   Azizy, Munir ^a   Bekiroglu, Nural ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Maltepe Medical Faculty Hospital   (Turkey)

Author keywords

C reactive protein; Cardiometabolic risk; Children; TC to HDL C ratio

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; ELEVATED BLOOD PRESSURE; FEMALE; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TURKISH CITIZEN; WAIST CIRCUMFERENCE; BLOOD; CARDIOVASCULAR DISEASE; GENETICS; GLUCOSE BLOOD LEVEL; INFLAMMATION; METABOLISM; PATHOLOGY; RISK FACTOR; TURKEY;

ADOLESCENT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHILD; CHOLESTEROL, HDL; DYSLIPIDEMIAS; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; OBESITY; RISK FACTORS; TRIGLYCERIDES; TURKEY;

EID: 84928827348     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2014.12.010     Document Type: Article

References (30)

1. J. Danesh, J.G. Wheeler, and G.M. Hirschfield C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
2. R. Weiss, J. Dziura, and T.S. Burgert Obesity and the metabolic syndrome in children and adolescents N Engl J Med 350 2004 2362 2374
3. M. Fröhlich, A. Imhof, and G. Berg Association between C-reactive protein and features of the metabolic syndrome: a population-based study Diabetes Care 23 2000 1835 1839
4. A. Pfützner, T. Schöndorf, M. Hanefeld, and T. Forst High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone J Diabetes Sci Technol 4 2010 706 716
5. E.S. Nakou, E.N. Liberopoulos, H.J. Milionis, and M.S. Elisaf The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview Curr Vasc Pharmacol 6 2008 258 270
6. P.M. Ridker, N.P. Paynter, N. Rifai, J.M. Gaziano, and N.R. Cook C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 118 2008 2243 2251
7. N. Mattsson, T. Ronnemaa, M. Juonala, J.S. Viikari, and O.T. Raitakari Childhood predictors of the metabolic syndrome in adulthood Ann Med 40 2008 542 552
8. S.E. Messiah, K.L. Arheart, G. Lopez-Mitnik, S.E. Lipshultz, and T.L. Miller Ethnic group differences in cardiometabolic disease risk factors independent of body mass index among American youth Obesity 21 2013 424 428
9. R. Jago, J.S. Harrell, R.G. McMurray, S. Edelstein, L.E. Ghormli, and S. Bassin Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications Pediatrics 117 2006 2065 2073
10. N. Hatipoglu, A. Ozturk, M.M. Mazicioglu, S. Kurtoglu, S. Seyhan, and F. Lokoglu Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents Eur J Pediatr 167 2008 383 389
11. T.J. Cole, M.C. Bellizzi, K.M. Flegal, and W.H. Dietz Establishing a standard definition for child overweight and obesity worldwide: international survey BMJ 320 2000 1240 1243
12. NGHS Coordinating Center NHLBI Growth and Health Study (NGHS) Data Monitoring Report 1998 Baltimore Maryland Medical Research Cincinnati, OH
13. B. Balkau, and M.A. Charles Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR) Diabet Med 16 1999 442 443
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
15. M. Laakso How good a marker is insulin level for insulin resistance? Am J Epidemiol 137 1993 959 965
16. N. Gungor, R. Saad, J. Janosky, and S. Arslanian Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents J Pediatr 144 2004 47 55
17. M. Keskin, S. Kurtoglu, M. Kendirci, M.E. Atabek, and C. Yazici Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents Pediatrics 115 2005 500 503
18. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
19. K.G. Alberti, P. Zimmet, J. Shaw IDF Epidemiology Task Force Consensus Group The metabolic syndrome - a new worldwide definition Lancet 366 2005 1059 1062
20. M. Juonala, C.G. Magnussen, and G.S. Berenson Childhood adiposity, adult adiposity, and cardiovascular risk factors N Engl J Med 365 2011 1876 1885
21. O. Neyzi, H.N. Saka, and S. Kurtoʇlu Anthropometric studies on the Turkish population- A historical review J Clin Res Pediatr Endocrinol 5 2013 1 12
22. R.W. Mahley, K.E. Palaoglu, and Z. Atak Turkish Heart Study: lipids, lipoproteins, and apolipoproteins J Lipid Res 36 1995 839 859
23. M. Agirbasli, G. Ciliv, S. Cakir, S. Srinivasan, G.S. Berenson, and S. Ozme Body mass index and lipid levels in children from Ankara, Turkey versus Bogalusa, Louisiana Prev Med 41 2005 843 845
24. A. Onat, G. Can, and G. Hergenç Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk Metabolism 57 2008 207 214
25. P.J. Kappelle, R.T. Gansevoort, J.L. Hillege, B.H. Wolffenbuttel, R.P. Dullaart PREVEND study group Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein J Intern Med 269 2011 232 242
26. A. Onat, M. Yüksel, and B. Köroʇlu Turk Turkish Adult Risk Factor Study survey 2012: overall and coronary mortality and trends in the prevalence of metabolic syndrome Turk Kardiyol Dern Ars 41 2013 373 378
27. A.R. Sinaiko, J. Steinberger, and A. Moran Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence Circulation 111 2005 1985 1991
28. M.D. DeBoer, M.J. Gurka, and A.E. Sumner Diagnosis of the metabolic syndrome is associated with disproportionately high levels of high-sensitivity C-reactive protein in non-Hispanic black adolescents: an analysis of NHANES 1999-2008 Diabetes Care 34 2011 734 740
29. A.C. Oliveira, A.M. Oliveira, L.F. Adan, N.F. Oliveira, A.M. Silva, and A.M. Ladeia C-reactive protein and metabolic syndrome in youth: a strong relationship? Obesity 16 2008 1094 1098
30. E.S. Ford, U.A. Ajani, and A.H. Mokdad The metabolic syndrome and concentrations of C-reactive protein among U.S. youth Diabetes Care 28 2005 878 881